Lung Cancer is the fastest growing segment, North America is the largest market globally
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.Key Market Challenges
The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.Key Market Trends
The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 70% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.Key Market Players Profiled:
- Siemens Healthineers AG
- Accuray Incorporated
- Elekta GmbH
- Iba LLC
- Hitachi, Ltd.
- Mevion Medical Systems B.V.
- Koninklijke Philips N.V.
- Raysearch Laboratories AB
- Brainlab AG
- HD Biosciences Co., Ltd.
Report Scope:
In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories:By Radiation Type:
- Proton radiation
- Electron radiation
- Photon radiation
- Carbon-lon radiation
By End User:
- Hospital & Clinics
- Ambulatory Surgical care
- Others
By Application:
- Prostate cancer
- Lung cancer
- Breast cancer
- Brain cancer
- Gynecological cancers
- Gastrointestinal cancers
- Other cancers
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Intensity Modulated Radiotherapy Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Siemens Healthineers AG
- Accuray Incorporated
- Elekta GmbH
- Iba LLC
- Hitachi, Ltd.
- Mevion Medical Systems B.V.
- Koninklijke Philips N.V.
- Raysearch Laboratories AB
- Brainlab AG
- HD Biosciences Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.01 Billion |
| Forecasted Market Value ( USD | $ 2.79 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |


